
WideTrial Provides Update on NIH-Funded Expanded Access Program for Investigational ALS Drug MN-166
Program expands patient access to ibudilast at multiple ALS centers across the U.S SANTA CLARA, CA, UNITED STATES, July 10, 2025 /EINPresswire.com/ -- WideTrial, an innovator of Expanded Access Program (EAP) solutions, today provided an update on its …